NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - Moleculin Biotech, Inc. - 5.07
Filed:
2026-04-15
AccNo:
0001437749-26-012325
Size:
210 KB
Item 5.07: Submission of Matters to a Vote of Security Holders
发布时间04/15 15:40 UTC
首次发现04/15 15:42 UTC
热度104.3
重要度54
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 747 字符
Form 8-K - Current report: SEC Accession No. 0001437749-26-012325
Filing Date: 2026-04-15
Accepted: 2026-04-15 11:40:38
Documents: 13
Period of Report: 2026-04-15
Items: Item 5.07: Submission of Matters to a Vote of Security Holders
Moleculin Biotech, Inc. (Filer) CIK : 0001659617 (see all company filings) EIN. : 474671997 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 26863165 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 8-K | mbrx20260408_8k.htm iXBRL | 8-K
6 | logobig.jpg | GRAPHIC | 19220
2 | XBRL TAXONOMY EXTENSION SCHEMA | mbrx-20260415.xsd | EX-101.SCH
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mbrx-20260415_def.xml | EX-101.DEF